Precision Biosciences (DTIL) Equity Ratio (2018 - 2025)
Historic Equity Ratio for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to 0.18.
- Precision Biosciences' Equity Ratio fell 5797.14% to 0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18, marking a year-over-year decrease of 5797.14%. This contributed to the annual value of 0.41 for FY2024, which is 25027.53% up from last year.
- According to the latest figures from Q3 2025, Precision Biosciences' Equity Ratio is 0.18, which was down 5797.14% from 0.31 recorded in Q2 2025.
- In the past 5 years, Precision Biosciences' Equity Ratio ranged from a high of 0.45 in Q2 2024 and a low of 0.12 during Q4 2023
- For the 5-year period, Precision Biosciences' Equity Ratio averaged around 0.31, with its median value being 0.31 (2025).
- Per our database at Business Quant, Precision Biosciences' Equity Ratio crashed by 5824.46% in 2021 and then soared by 25027.53% in 2024.
- Precision Biosciences' Equity Ratio (Quarter) stood at 0.43 in 2021, then crashed by 41.14% to 0.25 in 2022, then crashed by 53.48% to 0.12 in 2023, then soared by 250.28% to 0.41 in 2024, then tumbled by 56.98% to 0.18 in 2025.
- Its Equity Ratio stands at 0.18 for Q3 2025, versus 0.31 for Q2 2025 and 0.4 for Q1 2025.